Activation of the tgf- β pathway enhances the efficacy of platinum-based chemotherapy in small cell lung cancer patients

HIGHLIGHTS

• who: Anqi Lin et al. from the Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China have published the research work: Activation of the TGF- u03b2 Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients, in the Journal: Disease Markers 8 of 21/Dec/2022
• what: The results of the study showed that SCLC patients in the TGFB-HIGH group were characterized by immune activation and differential immune cell infiltration. u03b3/u03b4 T_cells can enhance carboplatin-induced cytotoxicity against advanced bladder cancer cells .
• how: The flowchart . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.